{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T21:44:54Z","timestamp":1783547094097,"version":"3.55.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2015,4,24]],"date-time":"2015-04-24T00:00:00Z","timestamp":1429833600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int J Clin Pharm"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1007\/s11096-015-0113-4","type":"journal-article","created":{"date-parts":[[2015,4,23]],"date-time":"2015-04-23T00:32:38Z","timestamp":1429749158000},"page":"566-578","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":40,"title":["Pharmacists\u2019 medicines-related interventions for people with intellectual disabilities: a narrative review"],"prefix":"10.1007","volume":"37","author":[{"given":"M\u00e1ire","family":"O\u2019Dwyer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arijana","family":"Me\u0161trovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Henman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,24]]},"reference":[{"key":"113_CR1","unstructured":"American Association on Intellectual and Developmental Disabilities. Definition of intellectual disability 2011. http:\/\/aaidd.org\/intellectual-disability\/definition#.VL-LRnu3G4c ."},{"issue":"1","key":"113_CR2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1741-1130.2010.00248.x","volume":"7","author":"M Haveman","year":"2010","unstructured":"Haveman M, Heller T, Lee L, Maaskant M, Shooshtari S, Strydom A. Major health risks in aging persons with intellectual disabilities: an overview of recent studies. J Policy Pract Intellect Disabil. 2010;7(1):59\u201369.","journal-title":"J Policy Pract Intellect Disabil"},{"issue":"1","key":"113_CR3","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/13668250.2010.549464","volume":"36","author":"M Haveman","year":"2011","unstructured":"Haveman M, Perry J, Salvador-Carulla L, Walsh PN, Kerr M, Van Schrojenstein LV, et al. Ageing and health status in adults with intellectual disabilities: results of the European POMONA II study. J Intellect Dev Disabil. 2011;36(1):49\u201360.","journal-title":"J Intellect Dev Disabil"},{"key":"113_CR4","doi-asserted-by":"crossref","unstructured":"Heslop P, Blair PS, Fleming P, Hoghton M, Marriott A, Russ L. The confidential inquiry into premature deaths of people with intellectual disabilities in the UK: a population-based study. Lancet. 2013;383(9920):889\u2013895.","DOI":"10.1016\/S0140-6736(13)62026-7"},{"issue":"2","key":"113_CR5","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1177\/1744629506064011","volume":"10","author":"KE Lavin","year":"2006","unstructured":"Lavin KE, McGuire BE, Hogan MJ. Age at death of people with an intellectual disability in Ireland. J Intellect Disabil. 2006;10(2):155\u201364.","journal-title":"J Intellect Disabil"},{"key":"113_CR6","unstructured":"Taylor D, Paton C, Kapur S. The Maudsley prescribing guidelines in psychiatry: Wiley. com; 2012."},{"issue":"3","key":"113_CR7","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1352\/1944-7558-119.3.253","volume":"119","author":"M McCarron","year":"2014","unstructured":"McCarron M, O\u2019Dwyer M, Burke E, McGlinchey E, McCallion P. Epidemiology of epilepsy in older adults with an intellectual disability in Ireland: associations and service implications. Am J Intellect Dev Disabil. 2014;119(3):253\u201360.","journal-title":"Am J Intellect Dev Disabil"},{"issue":"1","key":"113_CR8","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1192\/bjp.bp.106.022483","volume":"190","author":"S-A Cooper","year":"2007","unstructured":"Cooper S-A, Smiley E, Morrison J, Williamson A, Allan L. Mental ill-health in adults with intellectual disabilities: prevalence and associated factors. Br J Psychiatry. 2007;190(1):27\u201335.","journal-title":"Br J Psychiatry"},{"issue":"5","key":"113_CR9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1093\/fampra\/17.5.405","volume":"17","author":"HM Schrojenstein Lantman-De van","year":"2000","unstructured":"van Schrojenstein Lantman-De HM, Metsemakers JF, Haveman MJ, Crebolder HF. Health problems in people with intellectual disability in general practice: a comparative study. Fam Pract. 2000;17(5):405\u20137.","journal-title":"Fam Pract"},{"issue":"2","key":"113_CR10","first-page":"48","volume":"15","author":"C Mac Giolla Phadraig","year":"2014","unstructured":"Mac Giolla Phadraig C, el-Helaali R, Burke E, McCallion P, McGlinchey E, McCarron M, et al. National levels of reported difficulty in tooth and denture cleaning among an ageing population with intellectual disabilities in Ireland. J Disabil Oral Health. 2014;15(2):48\u201353.","journal-title":"J Disabil Oral Health"},{"issue":"1","key":"113_CR11","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.ridd.2012.07.029","volume":"34","author":"M McCarron","year":"2013","unstructured":"McCarron M, Swinburne J, Burke E, McGlinchey E, Carroll R, McCallion P. Patterns of multimorbidity in an older population of persons with an intellectual disability: results from the intellectual disability supplement to the Irish longitudinal study on aging (IDS-TILDA). Res Dev Disabil. 2013;34(1):521\u20137.","journal-title":"Res Dev Disabil"},{"issue":"2","key":"113_CR12","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1741-1130.2011.00297.x","volume":"8","author":"CE Townsend","year":"2011","unstructured":"Townsend CE. Developing a comprehensive research agenda for people with intellectual disability to inform policy development and reform. J Policy Pract Intellect Disabil. 2011;8(2):113\u201324.","journal-title":"J Policy Pract Intellect Disabil"},{"issue":"2","key":"113_CR13","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1192\/apt.8.2.138","volume":"8","author":"M Lindsey","year":"2002","unstructured":"Lindsey M. Comprehensive health care services for people with learning disabilities. Adv Psychiatry Treat. 2002;8(2):138\u201347.","journal-title":"Adv Psychiatry Treat"},{"issue":"1","key":"113_CR14","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1111\/j.1365-2788.2005.00663.x","volume":"49","author":"J Robertson","year":"2005","unstructured":"Robertson J, Emerson E, Pinkney L, Caesar E, Felce D, Meek A, et al. Treatment and management of challenging behaviours in congregate and noncongregate community-based supported accommodation. J Intellect Disabil Res. 2005;49(1):63\u201372.","journal-title":"J Intellect Disabil Res"},{"issue":"6","key":"113_CR15","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1046\/j.1365-2788.2000.00307.x","volume":"44","author":"J Robertson","year":"2000","unstructured":"Robertson J, Emerson E, Gregory N, Hatton C, Kessissoglou S, Hallam A. Receipt of psychotropic medication by people with intellectual disability in residential settings. J Intellect Disabil Res. 2000;44(6):666\u201376.","journal-title":"J Intellect Disabil Res"},{"issue":"4","key":"113_CR16","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1365-2788.1995.tb00518.x","volume":"39","author":"C Kiernan","year":"1995","unstructured":"Kiernan C, Reeves D, Alborz A. The use of anti-psychotic drugs with adults with learning disabilities and challenging behaviour. J Intellect Disabil Res. 1995;39(4):263\u201374.","journal-title":"J Intellect Disabil Res"},{"issue":"6","key":"113_CR17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1365-2788.1994.tb00459.x","volume":"38","author":"D Branford","year":"1994","unstructured":"Branford D. A study of the prescribing for people with learning disabilities living in the community and in national health service care. J Intellect Disabil Res. 1994;38(6):577\u201386.","journal-title":"J Intellect Disabil Res"},{"issue":"1","key":"113_CR18","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ridd.2009.08.002","volume":"31","author":"JL Matson","year":"2010","unstructured":"Matson JL, Fodstad JC, Neal D, Dempsey T, Rivet TT. Risk factors for tardive dyskinesia in adults with intellectual disability, comorbid psychopathology, and long-term psychotropic use. Res Dev Disabil. 2010;31(1):108\u201316.","journal-title":"Res Dev Disabil"},{"issue":"1","key":"113_CR19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1192\/apt.7.1.43","volume":"7","author":"SL Einfeld","year":"2001","unstructured":"Einfeld SL. Systematic management approach to pharmacotherapy for people with learning disabilities. Adv Psychiatry Treat. 2001;7(1):43\u20139.","journal-title":"Adv Psychiatry Treat"},{"issue":"534","key":"113_CR20","first-page":"64","volume":"57","author":"JM Straetmans","year":"2007","unstructured":"Straetmans JM, van Schrojenstein Lantman-de HM, Schellevis FG, Dinant G-J. Health problems of people with intellectual disabilities: the impact for general practice. Br J Gen Pract. 2007;57(534):64\u20136.","journal-title":"Br J Gen Pract"},{"issue":"3","key":"113_CR21","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1046\/j.1365-2125.2001.00347.x","volume":"51","author":"MS Roberts","year":"2001","unstructured":"Roberts MS, Stokes JA, King MA, Lynne TA, Purdie DM, Glasziou PP, et al. Outcomes of a randomized controlled trial of a clinical pharmacy intervention in 52 nursing homes. Br J Clin Pharmacol. 2001;51(3):257\u201365.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"113_CR22","doi-asserted-by":"crossref","first-page":"181","DOI":"10.7870\/cjcmh-2009-0014","volume":"28","author":"RA Lemay","year":"2009","unstructured":"Lemay RA. Deinstitutionalization of people with developmental disabilities: a review of the literature. Can J Community Ment Health. 2009;28(1):181\u201394.","journal-title":"Can J Community Ment Health"},{"issue":"7072","key":"113_CR23","first-page":"826","volume":"263","author":"J Barton","year":"1999","unstructured":"Barton J. Pharmacist support for people with learning disabilities. Pharm J. 1999;263(7072):826\u201331.","journal-title":"Pharm J"},{"issue":"3","key":"113_CR24","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s11096-014-9933-x","volume":"36","author":"SS Allemann","year":"2014","unstructured":"Allemann SS, van Mil JF, Botermann L, Berger K, Griese N, Hersberger KE. Pharmaceutical care: the PCNE definition 2013. Int J Clin Pharm. 2014;36(3):544\u201355.","journal-title":"Int J Clin Pharm"},{"issue":"4","key":"113_CR25","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1365-2788.2002.00408.x","volume":"46","author":"P Oliver","year":"2002","unstructured":"Oliver P, Piachaud J, Done J, Regan A, Cooray S, Tyrer P. Difficulties in conducting a randomized controlled trial of health service interventions in intellectual disability: implications for evidence-based practice. J Intellect Disabil Res. 2002;46(4):340\u20135.","journal-title":"J Intellect Disabil Res"},{"issue":"2","key":"113_CR26","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2788.1994.tb00373.x","volume":"38","author":"DJ Clarke","year":"1994","unstructured":"Clarke DJ, Pickles K. Lithium treatment for people with learning disability: patients \u2018and carers\u2019 knowledge of hazards and attitudes to treatment. J Intellect Disabil Res. 1994;38(2):187\u201394.","journal-title":"J Intellect Disabil Res"},{"issue":"5","key":"113_CR27","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/ajhp\/61.5.487","volume":"61","author":"NC Brahm","year":"2004","unstructured":"Brahm NC, Brown RC. Clinical pharmacology services: a pharmacist-based consulting service for the developmentally disabled. Am J Health Syst Pharm. 2004;61(5):487.","journal-title":"Am J Health Syst Pharm"},{"issue":"1","key":"113_CR28","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4140\/TCP.n.2004.45","volume":"19","author":"EV Schmidt","year":"2004","unstructured":"Schmidt EV, Byars JR, Flamuth DH, Schott JJ, Sever CM. Prevalence of low bone-mineral density among mentally retarded and developmentally disabled residents in intermediate care. Consult Pharm. 2004;19(1):45\u201351.","journal-title":"Consult Pharm"},{"issue":"1","key":"113_CR29","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1111\/j.1468-3156.2006.00419.x","volume":"35","author":"C Parkes","year":"2007","unstructured":"Parkes C, Samuels S, Hassiotis A, Lynggaard H, Hall I. Incorporating the views of service users in the development of an integrated psychiatric service for people with learning disabilities. Br J Learn Disabil. 2007;35(1):23\u20139.","journal-title":"Br J Learn Disabil"},{"issue":"2","key":"113_CR30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1468-3156.2001.00108.x","volume":"29","author":"A Strydom","year":"2001","unstructured":"Strydom A, Forster M, Wilkie B, Edwards C, Hall I. Patient information leaflets for people with learning disabilities who take psychiatric medication. Br J Learn Disabil. 2001;29(2):72\u20136.","journal-title":"Br J Learn Disabil"},{"issue":"11","key":"113_CR31","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/j.1365-2788.2009.01212.x","volume":"53","author":"J Idzinga","year":"2009","unstructured":"Idzinga J, De Jong A, Van Den Bemt P. The effect of an intervention aimed at reducing errors when administering medication through enteral feeding tubes in an institution for individuals with intellectual disability. J Intellect Disabil Res. 2009;53(11):932\u20138.","journal-title":"J Intellect Disabil Res"},{"issue":"4","key":"113_CR32","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1211\/ijpp.14.4.0006","volume":"14","author":"A Blasi Di","year":"2006","unstructured":"Di Blasi A, Kendall S, Spark MJ. Perspectives on the role of the community pharmacist in the provision of healthcare to people with intellectual disabilities: exploration of the barriers and solutions. Int J Pharm Pract. 2006;14(4):263\u20139.","journal-title":"Int J Pharm Pract"},{"key":"113_CR33","doi-asserted-by":"crossref","unstructured":"Thomsen LA, Rossing C, Trier H, Faber M, Herborg H. Improving safety in the medicines use process for disabled persons in residential facilities. Results from a pilot study. J Biosafety Health Educ. 2014;2:114. doi: 10.4172\/2332-0893.1000114","DOI":"10.4172\/2332-0893.1000114"},{"key":"113_CR34","doi-asserted-by":"crossref","unstructured":"Craig P, Dieppe P, Macintyre S, Michie S, Nazareth I, Petticrew M. Developing and evaluating complex interventions: the new medical research council guidance. BMJ. 2008;337:a1655. http:\/\/dx.doi.org\/10.1136\/bmj.a1655","DOI":"10.1136\/bmj.a1655"},{"key":"113_CR35","unstructured":"McCarron M, Swinburne J, Burke E, McGlinchey E, Mulryan N, Andrews V, Foran S, McCallion, P. Growing older with an intellectual disability in Ireland 2011: first results from the intellectual disability supplement of the Irish longitudinal study on ageing school of nursing, Trinity College Dublin. 2011."},{"key":"113_CR36","unstructured":"Ouellette-Kuntz HM, Lake JK, Wilton AS. 6 Medication use. Atlas on the primary care of adults with develop mental disabilities in Ontario. 2013;1:117."},{"issue":"7","key":"113_CR37","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1365-2788.2011.01421.x","volume":"55","author":"C Paton","year":"2011","unstructured":"Paton C, Flynn A, Shingleton-Smith A, McIntyre S, Bhaumik S, Rasmussen J, et al. Nature and quality of antipsychotic prescribing practice in UK psychiatry of intellectual disability services. J Intellect Disabil Res. 2011;55(7):665\u201374.","journal-title":"J Intellect Disabil Res"},{"issue":"6","key":"113_CR38","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1093\/ajhp\/34.6.604","volume":"34","author":"G Ellenor","year":"1977","unstructured":"Ellenor G, Frisk P. Pharmacist impact on drug use in an institution for the mentally retarded. Am J Health Syst Pharm. 1977;34(6):604\u20138.","journal-title":"Am J Health Syst Pharm"},{"issue":"10","key":"113_CR39","first-page":"1671","volume":"39","author":"RC Berchou","year":"1982","unstructured":"Berchou RC. Effect of a consultant pharmacist on medication use in an institution for the mentally retarded. Am J Hosp Pharm. 1982;39(10):1671\u20134.","journal-title":"Am J Hosp Pharm"},{"issue":"2","key":"113_CR40","first-page":"70","volume":"20","author":"F Inoue","year":"1982","unstructured":"Inoue F. A clinical pharmacy service to reduce psychotropic medication use in an institution for mentally handicapped persons. Ment Retard. 1982;20(2):70\u20134.","journal-title":"Ment Retard"},{"issue":"2","key":"113_CR41","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s11096-013-9900-y","volume":"36","author":"TE Richardson","year":"2014","unstructured":"Richardson TE, O\u2019Reilly CL, Chen TF. A comprehensive review of the impact of clinical pharmacy services on patient outcomes in mental health. Int J Clin Pharm. 2014;36(2):222\u201332.","journal-title":"Int J Clin Pharm"},{"key":"113_CR42","doi-asserted-by":"crossref","unstructured":"Finley PR, Crismon ML, Rush AJ. Evaluating the impact of pharmacists in mental health: a systematic review. Pharmacother J Hum Pharm Drug Ther. 2003;23(12):1634\u201344.","DOI":"10.1592\/phco.23.15.1634.31952"},{"issue":"6","key":"113_CR43","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1136\/qshc.2006.018267","volume":"15","author":"ID Maidment","year":"2006","unstructured":"Maidment ID, Lelliott P, Paton C. Medication errors in mental healthcare: a systematic review. Qual Saf Health Care. 2006;15(6):409\u201313.","journal-title":"Qual Saf Health Care"},{"issue":"5","key":"113_CR44","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1002\/gps.2745","volume":"27","author":"ID Maidment","year":"2012","unstructured":"Maidment ID, Fox C, Boustani M, Katona C. Medication management\u2014The missing link in dementia interventions. Int J Geriatr Psychiatry. 2012;27(5):439\u201342.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"6","key":"113_CR45","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/ageing\/afl075","volume":"35","author":"AG Zermansky","year":"2006","unstructured":"Zermansky AG, Alldred DP, Petty DR, Raynor DK, Freemantle N, Eastaugh J, et al. Clinical medication review by a pharmacist of elderly people living in care homes\u2014Randomised controlled trial. Age Ageing. 2006;35(6):586\u201391.","journal-title":"Age Ageing"},{"issue":"3","key":"113_CR46","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/ageing\/30.3.205","volume":"30","author":"J Krska","year":"2001","unstructured":"Krska J, Cromarty JA, Arris F, Jamieson D, Hansford D, Duffus PR, et al. Pharmacist-led medication review in patients over 65: a randomized, controlled trial in primary care. Age Ageing. 2001;30(3):205\u201311.","journal-title":"Age Ageing"},{"issue":"1","key":"113_CR47","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1186\/1471-244X-12-155","volume":"12","author":"A Child","year":"2012","unstructured":"Child A, Clarke A, Fox C, Maidment I. A pharmacy led program to review anti-psychotic prescribing for people with dementia. BMC Psychiatry. 2012;12(1):155.","journal-title":"BMC Psychiatry"},{"issue":"2","key":"113_CR48","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1007\/s11096-013-9875-8","volume":"36","author":"K Brownlie","year":"2014","unstructured":"Brownlie K, Schneider C, Culliford R, Fox C, Boukouvalas A, Willan C, et al. Medication reconciliation by a pharmacy technician in a mental health assessment unit. Int J Clin Pharm. 2014;36(2):303\u20139.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"113_CR49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/jppi.12064","volume":"11","author":"E Joos","year":"2014","unstructured":"Joos E, Mehuys E, Van Bocxlaer J, Remon JP, Van Winckel M, Boussery K. Medication management in Belgian residential care facilities for individuals with intellectual disability: an observational study. J Policy Pract Intellect Disabil. 2014;11(1):27\u201333.","journal-title":"J Policy Pract Intellect Disabil"},{"key":"113_CR50","doi-asserted-by":"crossref","unstructured":"Flood B, Henman MC. Building quality indicators for medication use in people aging with intellectual disabilities and behaviour disorders. Int J Dev Disabil. 2015. Published online: 6 Feb 2015. doi: 10.1179\/2047387714Y.0000000061 .","DOI":"10.1179\/2047387714Y.0000000061"}],"container-title":["International Journal of Clinical Pharmacy"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-015-0113-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11096-015-0113-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11096-015-0113-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T20:32:06Z","timestamp":1566592326000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11096-015-0113-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,24]]},"references-count":50,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["113"],"URL":"https:\/\/doi.org\/10.1007\/s11096-015-0113-4","relation":{},"ISSN":["2210-7703","2210-7711"],"issn-type":[{"value":"2210-7703","type":"print"},{"value":"2210-7711","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,24]]}}}